Jill Leversage serves as Executive at Aurinia Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Jill Leversage has executed 8 insider transactions totaling $171.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 21, 2024 involved selling 5,610 shares valued at $32.2K.
Jill Leversage currently holds 12,918 shares of Aurinia Pharmaceuticals Inc. (AUPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jill Leversage has been a net seller of AUPH stock. They have purchased $85.1K and sold $86.4K worth of shares.
Jill Leversage's most recent insider trade was on May 21, 2024, when they sold 5,610 shares at $5.74 per share.
Get notified when new Form 4 filings are submitted
| $11.26 |
| Discretionary |
| May 19, 2023 | AUPH | $0 | Award | 9,310 | $N/A | Discretionary |
| May 18, 2023 | AUPH | $0 | Option Exercise | 8,733 | $N/A | Discretionary |
| Dec 13, 2021 | AUPH | $32.1K | Purchase | 1,600 | $20.04 | Discretionary |
| May 11, 2021 | AUPH | $27.4K | Purchase | 2,500 | $10.96 | Discretionary |
| Jan 29, 2021 | AUPH | $19.2K | Purchase | 1,200 | $16.03 | Discretionary |
| Jan 29, 2021 | AUPH | $6.4K | Purchase | 400 | $16.03 | Discretionary |